18 September 2017
Researchers from the teams of Andrea Németh (NDCN) and Esther Becker (DPAG) have published an important paper reporting dominant mutations that cause a new type of cerebellar ataxia, Spinocerebellar Ataxia type 44.
10 April 2017
New research project could enable novel therapeutic approaches in Alzheimer’s and Parkinson’s diseases.
17 March 2017
Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine.
24 November 2016
A clear link between the activity in nerve clusters in the brain and the amount of force generated in a physical action has been demonstrated by our researchers, opening the way for the development of better devices to assist paralysed patients.
3 November 2016
New research from our Department has raised the possibility of minimising the side effects of treatment for patients with autoimmune diseases, such as multiple sclerosis and inflammatory bowel disease.
25 October 2016
Six universities including Oxford have been awarded a total of £4.3m by the Medical Research Council (MRC) to grow and develop the UK’s research base in dementia science.
1 September 2016
Scientists from the Oxford Parkinson’s Disease Centre (OPDC) and the Edinburgh Prion Unit have developed a new diagnostic test for Parkinson’s disease. The test measures the 'stickiness' of a particular protein in the cerebrospinal fluid.
9 August 2016
A spinout company from our Department, OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.
1 July 2016
The 12 winners of the inaugural University of Oxford's Vice-Chancellor’s Awards for Public Engagement with Research were announced on Friday 1 July by the Vice-Chancellor, Professor Louise Richardson, in a ceremony at Merton College.